Literature DB >> 8280313

An isoelastic prosthesis using a new composite material.

D Taylor1, C Martin, B Cornelis, M E Jones.   

Abstract

A new particulate composite material has been assessed with regard to the design of an 'isoelastic' or 'modulus matched' hip prosthesis. Three different prototype designs were assessed, each of which consisted of a femoral component made from the composite material, attached to a metal ball via a metal 'spike' insert. The prototypes varied in terms of the detailed shape of the spike, which was modified in the light of photoelastic stress analysis, so as to produce a more acceptable stress distribution to the composite material in the proximal region. Prototypes were made by hand moulding and by transfer moulding; both methods produced defects of various kinds. Simulation tests were conducted using a model of the proximal femur constructed from glass fibre composite, cyclically loaded in a servo-hydraulic testing machine. Though some difficulties were experienced with defective mouldings, especially for the transfer moulding process, a clear improvement was demonstrated for the final (Mark III) design. The fatigue endurance of this prototype was similar to that of conventional metal prostheses tested under similar conditions. Fatigue crack propagation tests were carried out on samples of the composite material to establish its propagation threshold. These results were combined with a finite element stress analysis and fracture mechanics theory to estimate the critical crack length for fatigue in this prosthesis. It was thus possible to specify the maximum safe size of defect that could be tolerated in use.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280313     DOI: 10.1243/PIME_PROC_1993_207_280_02

Source DB:  PubMed          Journal:  Proc Inst Mech Eng H        ISSN: 0954-4119            Impact factor:   1.617


  1 in total

1.  Performance of CF/PA12 composite femoral stems.

Authors:  Melissa Campbell; Martin N Bureau; L'Hocine Yahia
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.